Clinical trial
Caspofungin Acetate in Treating Children With Fever and Neutropenia
NCT00020527 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00020527 |
|---|---|
| Title | Caspofungin Acetate in Treating Children With Fever and Neutropenia |
| Official title | A Multicenter, Open, Non-Comparative, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Separate Doses of MK-0991 in Children With New Onset Fever and Neutropenia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Fever, Sweats, and Hot Flashes, Infection, Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Neutropenia, Sarcoma |
| Intervention type | Drug |
| Interventions | caspofungin acetate |
| Start date | Mar 1, 2001 |
| Completion | Jun 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: